These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2137808)

  • 21. [Hepatocyte growth factor in sera from patients with fulminant hepatic failure].
    Nakayama H; Tsubouchi H; Hirono S; Takahashi K; Miyazaki H
    Nihon Shokakibyo Gakkai Zasshi; 1985 Nov; 82(11):2857. PubMed ID: 4087488
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppression of transforming growth factor-beta results in upregulation of transcription of regeneration factors after chronic liver injury.
    Nakamura T; Ueno T; Sakamoto M; Sakata R; Torimura T; Hashimoto O; Ueno H; Sata M
    J Hepatol; 2004 Dec; 41(6):974-82. PubMed ID: 15582131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.
    Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD
    J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor.
    Tsubouchi H; Kawakami S; Hirono S; Miyazaki H; Kimoto M; Arima T; Sekiyama K; Yoshiba M; Arakaki N; Daikuhara Y
    Lancet; 1992 Aug; 340(8814):307. PubMed ID: 1353217
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term effect of hepatocyte transplantation on fulminant hepatic failure in rats.
    Ahmad TA; Fujioka H; Eguchi S; Yanaga K; Kamohara Y; Furui J; Kanematsu T
    Hepatogastroenterology; 2003; 50(50):467-71. PubMed ID: 12749249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent progress in hepatocyte growth factor research].
    Nakamura T
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2495-503. PubMed ID: 1836127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR.
    Passino MA; Adams RA; Sikorski SL; Akassoglou K
    Science; 2007 Mar; 315(5820):1853-6. PubMed ID: 17395831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of HGF-SF in animal and human hepatic physiology and pathology.
    Tsubouchi H; Gohda E; Strain AJ; Daikuhara Y
    EXS; 1993; 65():251-74. PubMed ID: 8422546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure.
    Gohda E; Tsubouchi H; Nakayama H; Hirono S; Takahashi K; Koura M; Hashimoto S; Daikuhara Y
    Exp Cell Res; 1986 Sep; 166(1):139-50. PubMed ID: 3527727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and change in the receptor for hepatocyte growth factor in rat liver after partial hepatectomy or induced hepatitis.
    Higuchi O; Nakamura T
    Biochem Biophys Res Commun; 1991 Apr; 176(2):599-607. PubMed ID: 1827259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic expression of hepatocyte growth factor gene mRNA in acute liver failure.
    Harrison P; Gove C; Bomford A
    Dig Dis Sci; 2000 Oct; 45(10):1913-20. PubMed ID: 11117560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Structure and function of hepatocyte growth factor].
    Takehara T; Nakamura T
    Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1227-36. PubMed ID: 1831277
    [No Abstract]   [Full Text] [Related]  

  • 33. Fulminant hepatic failure.
    Berk PD; Popper H
    Am J Gastroenterol; 1978 Mar; 69(3 Pt 2):349-400. PubMed ID: 685949
    [No Abstract]   [Full Text] [Related]  

  • 34. Growth factors and the liver.
    Selden AC; Hodgson HJ
    Gut; 1991 Jun; 32(6):601-3. PubMed ID: 1711993
    [No Abstract]   [Full Text] [Related]  

  • 35. Zinc content in liver of experimental fulminant hepatic failure rat.
    Kawanishi H; Nishiki M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1983 Sep; 32(3):305-9. PubMed ID: 6358141
    [No Abstract]   [Full Text] [Related]  

  • 36. Liver regeneration and growth factors: old puzzles and new perspectives.
    Michalopoulos G
    Lab Invest; 1992 Oct; 67(4):413-5. PubMed ID: 1434525
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases.
    Takiya S; Tagaya T; Takahashi K; Kawashima H; Kamiya M; Fukuzawa Y; Kobayashi S; Fukatsu A; Katoh K; Kakumu S
    J Clin Pathol; 1995 Dec; 48(12):1093-7. PubMed ID: 8567993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basic and clinical aspects of human hepatocyte growth factor].
    Tsubouchi H; Daikuhara Y
    Tanpakushitsu Kakusan Koso; 1992 Sep; 37(12):2135-43. PubMed ID: 1388283
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells.
    Schirmacher P; Geerts A; Pietrangelo A; Dienes HP; Rogler CE
    Hepatology; 1992 Jan; 15(1):5-11. PubMed ID: 1530788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary structure of rat hepatocyte growth factor and induction of its mRNA during liver regeneration following hepatic injury.
    Okajima A; Miyazawa K; Kitamura N
    Eur J Biochem; 1990 Oct; 193(2):375-81. PubMed ID: 2146117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.